Which funds bought or sold TXN in Q3 2026?
Texas Instrs Inc. 13 funds bought, 21 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$51M. See also what famous investors say about TXN.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
- Schwab+$1.5B
- BlackRock+$815M
- AQR+$766M
- Fidelity+$551M
- CalPERS+$382M
- Amundi+$264M
- D. E. Shaw+$259M
- Jennison+$215M
- Man Group+$202M
- Geode+$138M
- JPMorgan−$2.0B
- Wellington−$628M
- Jane Street−$453M
- Citadel−$445M
- Invesco−$364M
- Goldman Sachs−$269M
- QRT−$258M
- Balyasny−$212M
- Marshall Wace−$167M
- Ameriprise−$143M
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (13)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Schwab Index giant | Added+25.6% | +$1.5B | $7.4B |
| BlackRock Index giant | Added+3.5% | +$815M | $23.9B |
| AQR Quant & multi-strategy | Added+194.9% | +$766M | $1.2B |
| Fidelity Asset manager | Added+73.2% | +$551M | $1.3B |
| CalPERS Sovereign & pension | Added+84.3% | +$382M | $836M |
| Amundi Asset manager | Added+11% | +$264M | $2.7B |
| D. E. Shaw Quant & multi-strategy | Added+89.5% | +$259M | $548M |
| Jennison Growth / crossover | Added+24.4% | +$215M | $1.1B |
| Man Group Quant & multi-strategy | Added+200% | +$202M | $303M |
| Geode Index giant | Added+2.1% | +$138M | $6.9B |
| Glenview Hedge fund | New | +$40M | $40M |
| Legal & General Asset manager | Added+2.2% | +$39M | $1.8B |
| GQG Growth / crossover | New | +$20M | $20M |
Sold (21)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| JPMorgan Bank & broker | Trimmed-22.3% | −$2.0B | $7.1B |
| Wellington Asset manager | Trimmed-17.1% | −$628M | $3.0B |
| Jane Street Quant & multi-strategy | Trimmed-95.8% | −$453M | $20M |
| Citadel Quant & multi-strategy | Trimmed-77.3% | −$445M | $131M |
| Invesco Asset manager | Trimmed-3.4% | −$364M | $10.2B |
| Goldman Sachs Bank & broker | Trimmed-9.6% | −$269M | $2.5B |
| QRT Quant & multi-strategy | Trimmed-79.4% | −$258M | $67M |
| Balyasny Quant & multi-strategy | Trimmed-50.4% | −$212M | $209M |
| Marshall Wace Quant & multi-strategy | Trimmed-37.2% | −$167M | $282M |
| Ameriprise Asset manager | Trimmed-8.3% | −$143M | $1.6B |
| Capital Research Asset manager | Trimmed-7.3% | −$115M | $1.5B |
| CPP Investments Sovereign & pension | Trimmed-14.9% | −$100M | $570M |
| Renaissance Quant & multi-strategy | Trimmed-22.4% | −$88M | $305M |
| RBC Bank & broker | Trimmed-4.2% | −$85M | $1.9B |
| D1 Growth / crossover | Trimmed-74.3% | −$84M | $29M |
| Tudor Hedge fund | Sold out | −$83M | — |
| Wells Fargo Bank & broker | Trimmed-5.3% | −$63M | $1.1B |
| Schonfeld Quant & multi-strategy | Trimmed-86.7% | −$32M | $5M |
| Baillie Gifford Growth / crossover | Trimmed-6.2% | −$27M | $406M |
| First Eagle Value investor | Sold out | −$16M | — |
| Oakmark Value investor | Trimmed-2.6% | −$337K | $13M |
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.